Real Chemistry launches MaestroHCP for pharmaceutical omnichannel marketing
Real Chemistry, LLC →Real Chemistry announced MaestroHCP on October 1, 2026, introducing an AI-powered platform for pharmaceutical marketers to plan, activate and measure engagement with healthcare professionals. The system combines audience intelligence, approved content, channel requirements and performance information in one workflow. Its functions include individual engagement journeys, closed-loop measurement, investment decisioning and adaptive orchestration. Developed with the Amazon Web Services Professional Services team, the platform incorporates Amazon SageMaker and pharmaceutical marketing requirements. Users define operating guardrails for approved assets, channels and brand strategy. The company offers self-service, managed-service and blended approaches. Its workflows account for eligible audiences, channel affinity, pricing and regulatory guidance.